This study is accepting new patients by invitation only
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
Summary
- Eligibility
- for people ages 15 months and up (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioMarin Pharmaceutical
- ID
- NCT03989947
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated